Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
Collins
Rory
R
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D004739:England; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000517:prevention & control*; D019821:Simvastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin